• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

羊水胰岛素和C肽作为胎儿巨大儿、产伤及分娩并发症的预测标志物?

Amniotic fluid insulin and C-peptide as predictive markers for fetal macrosomia, birth injuries, and delivery complications?

作者信息

Stein Roland Gregor, Meinusch Malgorzata, Diessner Joachim, Dietl Johannes, Hönig Arnd, Zollner Ursula

机构信息

Department of Gynecology and Obstetrics, Würzburg University Hospital, Würzburg, Germany.

出版信息

Med Sci Monit. 2014 Jan 15;20:54-8. doi: 10.12659/MSM.889503.

DOI:10.12659/MSM.889503
PMID:24423633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3907493/
Abstract

BACKGROUND

Gestational diabetes mellitus (GDM) occurs in 3-5% of all pregnancies. GDM increases both maternal and fetal risks, causes fetal macrosomia, and hence increases the rates of caesarean sections and delivery complications such as shoulder dystocia. An early predictive marker and consequent early treatment could be beneficial, so amniotic fluid insulin and C-peptide have been examined in several studies. Increased amniotic fluid insulin in early amniocentesis between the 14th and 20th gestational week predicted a later GDM. A potential direct association with fetal macrosomia remains to be determined.

MATERIAL AND METHODS

This retrospective study investigated amniotic fluid insulin/C-peptide from amniocenteses between 14 and 20 weeks of gestation in correlation with fetal birth weight, type of delivery, and complications. To focus on effects of fetal hyperinsulinism apart from therapeutic confounders, we included patients who did not participate in GDM screening. Insulin and C-peptide were measured in 144 samples of frozen amniotic fluid. Birth weight, type of delivery, complications, and birth injuries were noted.

RESULTS

Birth weights ranged from 760 g to 4410 g with a mean weight of 3424 g at an average of 40 weeks gestation. The mean amniotic fluid insulin was 4.36 U/ml and the mean C-peptide concentration was 0.076 ng/ml. There was no correlation between amniotic fluid insulin or C peptide and birth weight, type of delivery, complications, and birth injuries.

CONCLUSIONS

Amniotic fluid insulin and C-peptide are unsuitable as predictive marker for fetal macrosomia, type of delivery, complications, or birth injuries.

摘要

背景

妊娠期糖尿病(GDM)在所有妊娠中发生率为3% - 5%。GDM会增加母婴风险,导致胎儿巨大,从而增加剖宫产率以及分娩并发症如肩难产的发生率。一种早期预测标志物及随之而来的早期治疗可能有益,因此在多项研究中对羊水胰岛素和C肽进行了检测。妊娠第14至20周早期羊膜腔穿刺时羊水胰岛素升高预示着后期会发生GDM。与胎儿巨大症的潜在直接关联仍有待确定。

材料与方法

这项回顾性研究调查了妊娠14至20周羊膜腔穿刺获取的羊水胰岛素/C肽,并将其与胎儿出生体重、分娩方式及并发症进行关联分析。为聚焦胎儿高胰岛素血症的影响而排除治疗干扰因素,我们纳入了未参加GDM筛查的患者。对144份冷冻羊水样本进行了胰岛素和C肽检测。记录了出生体重、分娩方式、并发症及出生损伤情况。

结果

出生体重范围为760克至4410克,平均体重为3424克,平均孕周为40周。羊水胰岛素平均为4.36 U/ml,C肽平均浓度为0.076 ng/ml。羊水胰岛素或C肽与出生体重、分娩方式、并发症及出生损伤之间无相关性。

结论

羊水胰岛素和C肽不适宜作为胎儿巨大症、分娩方式、并发症或出生损伤的预测标志物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6974/3907493/689dd42e88f5/medscimonit-20-54-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6974/3907493/2692cc5c273a/medscimonit-20-54-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6974/3907493/fa0fcf49f6f8/medscimonit-20-54-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6974/3907493/7e9b9c540fc0/medscimonit-20-54-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6974/3907493/9691e7da9d02/medscimonit-20-54-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6974/3907493/a05907531665/medscimonit-20-54-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6974/3907493/689dd42e88f5/medscimonit-20-54-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6974/3907493/2692cc5c273a/medscimonit-20-54-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6974/3907493/fa0fcf49f6f8/medscimonit-20-54-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6974/3907493/7e9b9c540fc0/medscimonit-20-54-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6974/3907493/9691e7da9d02/medscimonit-20-54-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6974/3907493/a05907531665/medscimonit-20-54-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6974/3907493/689dd42e88f5/medscimonit-20-54-g006.jpg

相似文献

1
Amniotic fluid insulin and C-peptide as predictive markers for fetal macrosomia, birth injuries, and delivery complications?羊水胰岛素和C肽作为胎儿巨大儿、产伤及分娩并发症的预测标志物?
Med Sci Monit. 2014 Jan 15;20:54-8. doi: 10.12659/MSM.889503.
2
Amniotic fluid insulin at 14-20 weeks' gestation: association with later maternal glucose intolerance and birth macrosomia.孕14 - 20周羊水胰岛素水平:与后期母体糖耐量异常及巨大儿出生的关联
Diabetes Care. 2001 Jul;24(7):1259-63. doi: 10.2337/diacare.24.7.1259.
3
Fetal hyperinsulinism at 14-20 weeks and subsequent gestational diabetes.孕14至20周时的胎儿高胰岛素血症及随后的妊娠期糖尿病。
Obstet Gynecol. 1996 Jan;87(1):89-93. doi: 10.1016/0029-7844(95)00361-4.
4
Amniotic fluid insulin levels identify the fetus at risk of neonatal hypoglycaemia.羊水胰岛素水平可识别有新生儿低血糖风险的胎儿。
Diabet Med. 1999 Jul;16(7):568-72. doi: 10.1046/j.1464-5491.1999.00104.x.
5
[Early diagnosis of gestational diabetes by amniotic fluid insulin levels?].通过羊水胰岛素水平早期诊断妊娠期糖尿病?
Z Geburtshilfe Neonatol. 2011 Jun;215(3):98-104. doi: 10.1055/s-0031-1271744. Epub 2011 Jul 13.
6
[Correlation between amniotic fluid glucose concentration and amniotic fluid volume and neonatal birth weight in pregnancy complicated by gestational diabetes mellitus].妊娠合并妊娠期糖尿病时羊水葡萄糖浓度与羊水量及新生儿出生体重的相关性
Zhonghua Fu Chan Ke Za Zhi. 2006 Nov;41(11):724-8.
7
Prediction of birthweight and risk of macrosomia in pregnancies complicated by diabetes.预测糖尿病孕妇的出生体重和巨大儿风险。
Am J Obstet Gynecol MFM. 2023 Aug;5(8):101042. doi: 10.1016/j.ajogmf.2023.101042. Epub 2023 Jun 6.
8
Relation of amniotic fluid C-peptide levels to neonatal body composition.羊水C肽水平与新生儿身体组成的关系。
Obstet Gynecol. 1994 Jul;84(1):96-100.
9
Amniotic fluid insulin values in women with gestational diabetes as a predictor of emerging diabetes mellitus.妊娠糖尿病女性的羊水胰岛素值作为新发糖尿病的预测指标
Aust N Z J Obstet Gynaecol. 1993 Nov;33(4):358-61. doi: 10.1111/j.1479-828x.1993.tb02108.x.
10
Second trimester maternal plasma and amniotic fluid adipokines in women who will develop gestational diabetes mellitus.孕中期将发生妊娠期糖尿病的女性的母血血浆和羊水脂肪因子
Gynecol Endocrinol. 2015;31(12):934-8. doi: 10.3109/09513590.2015.1079611. Epub 2015 Sep 15.

引用本文的文献

1
Effects of enteral insulin on enteral diet tolerance in premature infants: systematic review.肠内胰岛素对早产儿肠内饮食耐受性的影响:系统评价
Rev Paul Pediatr. 2024 Dec 20;43:e2024115. doi: 10.1590/1984-0462/2025/43/2024115. eCollection 2024.
2
Biomarkers for Macrosomia Prediction in Pregnancies Affected by Diabetes.糖尿病影响妊娠中巨大儿预测的生物标志物
Front Endocrinol (Lausanne). 2018 Jul 31;9:407. doi: 10.3389/fendo.2018.00407. eCollection 2018.
3
Macronutrient Composition or Social Determinants? Impact on Infant Outcomes With Gestational Diabetes Mellitus.

本文引用的文献

1
[Early diagnosis of gestational diabetes by amniotic fluid insulin levels?].通过羊水胰岛素水平早期诊断妊娠期糖尿病?
Z Geburtshilfe Neonatol. 2011 Jun;215(3):98-104. doi: 10.1055/s-0031-1271744. Epub 2011 Jul 13.
2
Maternal and neonatal outcomes and time trends of gestational diabetes mellitus in Sweden from 1991 to 2003.1991 年至 2003 年瑞典妊娠糖尿病的母婴结局和时间趋势。
Diabet Med. 2010 Apr;27(4):436-41. doi: 10.1111/j.1464-5491.2010.02978.x.
3
Determinants of gestational diabetes mellitus: A case control study in a district tertiary care hospital in south India.
宏量营养素组成还是社会决定因素?对妊娠期糖尿病婴儿结局的影响
Diabetes Spectr. 2016 May;29(2):71-8. doi: 10.2337/diaspect.29.2.71.
4
Assessment of Macular Peripapillary Nerve Fiber Layer and Choroidal Thickness Changes in Pregnant Women with Gestational Diabetes Mellitus, Healthy Pregnant Women, and Healthy Non-Pregnant Women.妊娠糖尿病孕妇、健康孕妇及健康非孕妇黄斑周围神经纤维层和脉络膜厚度变化的评估
Med Sci Monit. 2015 Jun 18;21:1759-64. doi: 10.12659/MSM.893221.
妊娠期糖尿病的决定因素:印度南部一家区级三级护理医院的病例对照研究。
Int J Diabetes Dev Ctries. 2010 Apr;30(2):91-6. doi: 10.4103/0973-3930.62599.
4
Cause of death in infants of women with pregestational diabetes mellitus and the relationship with glycemic control.孕前糖尿病女性所生婴儿的死因及其与血糖控制的关系。
Postgrad Med. 2009 Jul;121(4):26-32. doi: 10.3810/pgm.2009.07.2026.
5
How do we reduce the number of cases of missed postpartum diabetes in women with recent gestational diabetes mellitus?我们如何减少近期患有妊娠糖尿病的女性产后糖尿病漏诊的病例数?
Diabetes Care. 2009 Nov;32(11):1960-4. doi: 10.2337/dc09-0627. Epub 2009 Jul 29.
6
Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics.高血糖与不良妊娠结局(HAPO)研究:与新生儿人体测量学的关联
Diabetes. 2009 Feb;58(2):453-9. doi: 10.2337/db08-1112. Epub 2008 Nov 14.
7
Borderline gestational diabetes mellitus and pregnancy outcomes.边缘性妊娠糖尿病与妊娠结局
BMC Pregnancy Childbirth. 2008 Jul 30;8:31. doi: 10.1186/1471-2393-8-31.
8
Outcomes of pregnancies in women with pre-gestational diabetes mellitus and gestational diabetes mellitus; a population-based study in New South Wales, Australia, 1998-2002.孕前糖尿病和妊娠期糖尿病女性的妊娠结局;1998 - 2002年澳大利亚新南威尔士州的一项基于人群的研究
Diabet Med. 2008 Jun;25(6):708-15. doi: 10.1111/j.1464-5491.2008.02431.x.
9
Predictors of postpartum diabetes in women with gestational diabetes mellitus.妊娠期糖尿病女性产后糖尿病的预测因素
Diabetes. 2006 Mar;55(3):792-7. doi: 10.2337/diabetes.55.03.06.db05-0746.
10
Prevalence of impaired glucose tolerance 6 years after gestational diabetes.妊娠糖尿病6年后糖耐量受损的患病率
Exp Clin Endocrinol Diabetes. 2006 Jan;114(1):11-7. doi: 10.1055/s-2005-873015.